Related Experiment Video
Updated: Feb 15, 2026

An Aptamer-based Sensor for Unchelated GadoliniumIII
Published on: January 9, 2017
Frequency and Severity of Acute Allergic-Like Reactions to Intravenously Administered Gadolinium-Based Contrast Media
Monica M Forbes-Amrhein1, Jonathan R Dillman, Andrew T Trout
1From the Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Insights
Allergic-like reactions to gadolinium-based contrast media (GBCM) in children are rare and similar across different agents. A temporary increase in reactions was noted during a GBCM transition period, likely due to the Weber effect.
Area of Science:
- Pediatric Radiology
- Pharmacovigilance
- Medical Imaging
Background:
- Gadolinium-based contrast media (GBCM) are essential for pediatric imaging.
- Transitioning between GBCM agents requires careful monitoring for adverse events.
- Understanding reaction frequencies is crucial for patient safety.
Purpose of the Study:
- To determine the frequency and severity of acute allergic-like reactions to GBCM in children.
- To compare reaction rates before, during, and after a switch from gadopentetate dimeglumine to gadoterate meglumine.
- To assess the safety profile of gadoterate meglumine in a pediatric population.
Main Methods:
- Retrospective analysis of 32,365 GBCM administrations in pediatric patients (2009-2017).
- Identification and classification of allergic-like reactions from institutional databases.
- Comparison of reaction frequencies between different GBCM agents using chi-squared tests.
Main Results:
- Overall allergic-like reaction frequency to GBCM was low (0.06%).
- No significant difference in reaction rates was found among gadofosveset trisodium, gadoxetate disodium, gadoterate meglumine, and gadopentetate dimeglumine.
- A transient increase in reaction frequency (0.20%) was observed during the transition period from gadopentetate dimeglumine to gadoterate meglumine.
Conclusions:
- Allergic-like reactions to GBCM in children are rare and generally mild to moderate.
- Gadoterate meglumine demonstrates a comparable safety profile to other GBCMs.
- The observed increase in reactions during the transition period is likely attributable to the Weber effect, not an inherent property of the new GBCM.
Objectives:
The purpose of this study is to determine the frequency and severity of acute allergic-like reactions to gadolinium-based contrast media (GBCM) in children before, during, and after the transition from gadopentetate dimeglumine to gadoterate meglumine as our primary clinical GBCM.
Materials And Methods:
Institutional review board approval was obtained for this Health Insurance Portability and Accountability Act-compliant retrospective investigation. Allergic-like reactions to GBCM in pediatric patients were retrospectively assessed from January 2009 to January 2017, which included a departmental change of GBCM from gadopentetate dimeglumine to gadoterate meglumine. Allergic-like reactions were identified from departmental and hospital databases. The number of doses of GBCM was obtained from billing data. Allergic-like reaction frequencies for each GBCM were calculated and compared using the chi-squared test.
Results:
A total of 32,365 administrations of GBCM occurred during the study period (327 for gadofosveset trisodium; 672 for gadoxetate disodium; 12,012 for gadoterate meglumine; and 19,354 for gadopentetate dimeglumine). Allergic-like reactions occurred after 21 (0.06%) administrations. Reaction frequencies were not significantly different among the GBCM (0.3% gadofosveset trisodium; 0% gadoxetate disodium, 0.06% gadoterate meglumine, 0.08% gadopentetate dimeglumine; P > 0.05). Ten (47.6%) reactions were mild, 10 (47.6%) were moderate, and 1 (4.8%) was severe. The overall reaction frequency peaked during the 6-month transition period from gadopentetate dimeglumine to gadoterate meglumine (0.20%), compared with 0.07% pretransition (P = 0.048) and 0.04% posttransition (P = 0.0095).
Conclusion:
Allergic-like reactions to GBCM in children are rare. Gadoterate meglumine has a reaction frequency that does not significantly differ from other GBCMs. During the transition from gadopentetate dimeglumine to gadoterate meglumine, an increase in the frequency of reported allergic-like reactions was observed, likely reflective of the Weber effect.
Related Concept Videos
Allergic Reactions
Allergic Reactions: Anaphylaxis
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Acids, Bases and Neutralization Reactions
Acids, Bases and Neutralization Reactions

